Investigation of a New Material for Heart Valve Tissue Engineering by Brougham, Claire et al.
Technological University Dublin 
ARROW@TU Dublin 
Conference Papers Biomedical Devices and Assistive Technology Research Group 
2012-01-27 
Investigation of a New Material for Heart Valve Tissue 
Engineering 
Claire Brougham 
Technological University Dublin, claire.brougham@tudublin.ie 
Nian Shen 
Trinity College Dublin 
Allison Cudsworth 
Trinity College Dublin 
Thomas Flanagan 
Trinity College Dublin 
Stefan Jockenhoevel 
Aachen University of Technology 
See next page for additional authors 
Follow this and additional works at: https://arrow.tudublin.ie/biodevcon 
 Part of the Biology and Biomimetic Materials Commons, and the Biomaterials Commons 
Recommended Citation 
Brougham, C.et al. (2012) Investigation of a New Material For Heart Valve Tissue Engineering. Royal 
Academy of Medicine, Bioengineering in Ireland conference 18 January. 
This Conference Paper is brought to you for free and 
open access by the Biomedical Devices and Assistive 
Technology Research Group at ARROW@TU Dublin. It has 
been accepted for inclusion in Conference Papers by an 
authorized administrator of ARROW@TU Dublin. For more 
information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
Authors 
Claire Brougham, Nian Shen, Allison Cudsworth, Thomas Flanagan, Stefan Jockenhoevel, and Fergal 
O'Brien 
This conference paper is available at ARROW@TU Dublin: https://arrow.tudublin.ie/biodevcon/8 
TEMPLATE DESIGN © 2008 
www.PosterPresentations.com 
Claire Brougham
1,2
, Nian Shen
3, 4
, Allison Cudsworth
 3
, Thomas C. Flanagan
5
, 
Stefan Jockenhoevel 
4, Fergal J.O’Brien1,3  
 
 
1
 Department of Anatomy, Royal College of Surgeons in Ireland, Dublin, Ireland. 
2
 Biomedical Devices and Assistive Technology Research Group, DIT  
3 
Trinity Centre for Bioengineering, Trinity College Dublin 
4 
Helmholtz Institute for Biomedical Engineering & Institute for Textile Engineering 
University Hospital Aachen | RWTH Aachen University 
5
 School of Medicine & Medical Science, University College Dublin  
Introduction  
• Approx 300,000 heart valve replacements are 
performed annually however, current treatment 
options have limited success. 
 
 
• Current therapies cannot grow or remodel with the 
patient. These shortcomings have prompted 
increased focus on tissue engineering techniques to 
create fully autologous heart valve replacements.  
 
 
• Despite significant advances in the field of heart 
valve tissue engineering, a major problem is the 
inability of valves to maintain an appropriate seal 
upon closure as a result of cell-mediated retraction 
of the leaflets [1].  
 
 
 
 
 
 
 
 
 
 
 
 
 
• We are currently investigating natural biomaterials 
(collagen, glycosaminoglycans (GAGs) and fibrin) 
for the development of a scaffold which will have 
sufficient stiffness to resist the contractile forces of 
cells acting upon it. 
 
 
• The novel scaffold proposed is based around the 
concept of reinforcing cell-seeded fibrin gel 
component [3] with a collagen-GAG (CG) matrix.  
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On-going Work 
Figure 5. Masson’s Trichrome staining of a section 
of CG (blue) with fibrin (red) showing that the fibrin 
has completely permeated the CG scaffold.  
• This study has led to the development of a freeze-
dried CG-fibrin scaffold which will be used for heart 
valve tissue engineering.  
 
• This CG scaffold has a homogeneous pore structure 
throughout and can be manufactured in a 
repeatable, 3-D form.  
 
• The proof of principle that fibrin can be successfully 
infiltrated into the CG material has been 
demonstrated.  
 
• The stable ratio of fibrin to CG has been established 
at 0.7μl per mm3 CG. 
 
• A method of injecting the fibrin into the CG has been 
developed which has demonstrated full infiltration of 
the fibrin through the CG. 
 
• The use of crosslinking has been found to increase 
the compressive and tensile moduli of the material 
backbone which will improve the ability of the 
material to withstand the contractile forces of the 
cells on the material.  
Figure 6. SEM image of freeze-dried CG material 
(A), infiltrated with fibrin (B) using an injection 
method.  
• The tensile and compressive moduli of the materials 
were also tested and the crosslinking greatly 
enhanced the stiffness of the material.  
• Hypothesis: A CG-fibrin scaffold will provide sufficient 
structural stiffness to resist the contractile forces of 
cells.  
 
 
• Aim of this study: Develop a method of fabricating the 
CG-fibrin scaffold and analyse the resulting material. 
Figure 3. The image above shows the CG freeze 
dried construct. Through optimisation of the freeze 
drying process, a  tri-leaflet valve was fabricated.  
Figure 4. Masson’s Trichrome staining was used to 
assess the pore size and porosity of the scaffolds 
produced using a variety of freeze drying 
parameters. This image shown is from the 
optimised set of parameters. It shows a 
homogenous pore structure with an average pore 
size of 128.9 39.3μm and a porosity of 99.2% 
Analysis was completed at the top, in the middle 
leaflet section and at the lower section of the 
scaffold.  
Figure 1. This image shows a 
native aortic valve (taken 
from the arterial side) [2] 
where the leaflets form a 
closed seal. In cases of heart 
valve disease the shape or 
elasticity of the leaflets 
prevents this seal forming 
which means that there is a 
leakage of blood through the 
valve.  
• Freeze drying parameters such as final freezing 
temperature, cooling rate and drying times were 
optimised to produce a CG scaffold with a homogenous 
pore size structure [6]. 
 
 
• The freeze drying cycle optimisation was assessed 
using SEM, pore size and porosity analysis. 
• Scaffolds were crosslinked physically by 
dehydrothermal (DHT) cross-linking at 105ºC for 24 
hours. They were subsequently chemically crosslinked 
using 1-Ethyl-3-(3-dimethyl aminopropyl) carbodiimide 
(EDAC) in the presence of N-hydroxysuccinimide 
(NHS), solution which stiffens the scaffold while 
maintaining elasticity [7]. 
 
• To infiltrate the CG material with fibrin (a four stage 
solution which polymerises once the final ingredient is 
added), both drop loading and injection methods were 
assessed.  
 
• Masson’s Trichrome staining and SEM were used to 
assess the distribution of the fibrin throughout the CG 
material.  
 
• Mechanical properties were tested using a Zwick/Roell 
Z050 testing machine.  
Materials and methods 
Figure 2. We have 
previously developed a 
mould for the 
construction of tri-
leaflet heart valve 
conduits [1,4,5] This 
mould was modified for 
producing freeze-dried 
CG scaffolds. 
• Successful development of a freeze dried CG 
material with a homogenous structure in a tri- leaflet 
valve conduit shape.  
• We successfully developed of a method of infiltrating 
the CG scaffold with fibrin using an injection 
technique. Through optimisation of fibrin infiltration, 
a final volume of 0.7μl of fibrin gel per mm3 of CG 
was established as the most stable ratio.  
• The next phase of this study is to introduce cells to the 
scaffold in order to assess the biological performance 
of the material. This will also demonstrate the 
resistance of the material to the contractile forces 
exerted by the cells.  
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• Drop loading resulted in a layer of fibrin being 
established on the edges of the material due to the 
rapid polymerisation time of fibrin. Injection of the 
fibrin solution allowed for an even distribution of 
polymerised fibrin throughout the material as 
demonstrated in the SEM image shown. 
INVESTIGATION OF A NEW MATERIAL FOR HEART VALVE TISSUE ENGINEERING 
• A CG scaffold will be fabricated through freeze drying in 
a 3-D mould (Figure 2). 
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